There was a significantly higher frequency of insulin treatment during pregnancy in the obese group 2 and 4 compared with the young and non-obese group 1 GDM (17.4% and 15.7% vs. 8.2%, p < 0.05). This evidence concerns the gene INS and gestational diabetes.